183 related articles for article (PubMed ID: 30712460)
1. Identification of aberrant gene expression during breast ductal carcinoma
Song G; He L; Yang X; Yang Y; Cai X; Liu K; Feng G
J Int Med Res; 2020 Jan; 48(1):300060518815364. PubMed ID: 30712460
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of ductal carcinomas in situ and invasive breast tumors.
Seth A; Kitching R; Landberg G; Xu J; Zubovits J; Burger AM
Anticancer Res; 2003; 23(3A):2043-51. PubMed ID: 12894577
[TBL] [Abstract][Full Text] [Related]
3. Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer.
Elias EV; de Castro NP; Pineda PH; Abuázar CS; Bueno de Toledo Osorio CA; Pinilla MG; da Silva SD; Camargo AA; Silva WA; E Ferreira EN; Brentani HP; Carraro DM
Oncotarget; 2016 Nov; 7(46):75672-75684. PubMed ID: 27708222
[TBL] [Abstract][Full Text] [Related]
4. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.
Asch HL; Winston JS; Edge SB; Stomper PC; Asch BB
Breast Cancer Res Treat; 1999 May; 55(2):179-88. PubMed ID: 10481945
[TBL] [Abstract][Full Text] [Related]
6. Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis.
Rane SU; Mirza H; Grigoriadis A; Pinder SE
Breast Cancer Res Treat; 2015 Aug; 153(1):101-21. PubMed ID: 26255059
[TBL] [Abstract][Full Text] [Related]
7. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.
Nass SJ; Herman JG; Gabrielson E; Iversen PW; Parl FF; Davidson NE; Graff JR
Cancer Res; 2000 Aug; 60(16):4346-8. PubMed ID: 10969774
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ.
Helczynska K; Kronblad A; Jögi A; Nilsson E; Beckman S; Landberg G; Påhlman S
Cancer Res; 2003 Apr; 63(7):1441-4. PubMed ID: 12670886
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of the tumor microenvironment in breast cancer.
Allinen M; Beroukhim R; Cai L; Brennan C; Lahti-Domenici J; Huang H; Porter D; Hu M; Chin L; Richardson A; Schnitt S; Sellers WR; Polyak K
Cancer Cell; 2004 Jul; 6(1):17-32. PubMed ID: 15261139
[TBL] [Abstract][Full Text] [Related]
11. [Recent advances in studies on in-situ and invasive ductal carcinoma].
Zhang RJ; Niu Y; Gao YX
Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):63-5. PubMed ID: 19489232
[No Abstract] [Full Text] [Related]
12. Ductal carcinoma in situ of the breast: histological classification and genetic alterations.
van de Vijver MJ
Recent Results Cancer Res; 1998; 152():123-34. PubMed ID: 9928552
[TBL] [Abstract][Full Text] [Related]
13. p63 expression in normal, hyperplastic and malignant breast tissues.
Wang X; Mori I; Tang W; Nakamura M; Nakamura Y; Sato M; Sakurai T; Kakudo K
Breast Cancer; 2002; 9(3):216-9. PubMed ID: 12185332
[TBL] [Abstract][Full Text] [Related]
14. Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.
Munn KE; Walker RA; Menasce L; Varley JM
Br J Cancer; 1996 Nov; 74(10):1578-85. PubMed ID: 8932338
[TBL] [Abstract][Full Text] [Related]
15. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.
Barham W; Chen L; Tikhomirov O; Onishko H; Gleaves L; Stricker TP; Blackwell TS; Yull FE
BMC Cancer; 2015 Sep; 15():647. PubMed ID: 26424146
[TBL] [Abstract][Full Text] [Related]
16. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor.
Lawrence JA; Merino MJ; Simpson JF; Manrow RE; Page DL; Steeg PS
Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):29-35. PubMed ID: 9456240
[TBL] [Abstract][Full Text] [Related]
17. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.
Buerger H; Simon R; Schäfer KL; Diallo R; Littmann R; Poremba C; van Diest PJ; Dockhorn-Dworniczak B; Böcker W
Mol Pathol; 2000 Jun; 53(3):118-21. PubMed ID: 10897329
[TBL] [Abstract][Full Text] [Related]
18. Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade.
Sowter HM; Ferguson M; Pym C; Watson P; Fox SB; Han C; Harris AL
J Pathol; 2003 Dec; 201(4):573-80. PubMed ID: 14648660
[TBL] [Abstract][Full Text] [Related]
19. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
20. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
